Found 38 matching trials
A Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer PHASE3 This is a randomized, open-label, three-arm, phase 3 study in men with bioc...
Show More Location
The Mayo Clinic - Phoenix
Learn More & Join Trial
Degarelix as Second-Line Hormonal Treatment After Prostate-specific Antigen (PSA)-Failure in GnRH Agonist Treated Patients With Prostate Cancer PHASE2 This was an open-label, multi-centre, uncontrolled, exploratory trial with ...
Show More Location
Urologische Praxis
Learn More & Join Trial
Combining Ipilimumab, Degarelix, and Radical Prostatectomy in Men With Newly Diagnosed Metastatic Castration Sensitive Prostate Cancer or Ipilimumab and Degarelix in Men With Biochemically Recurrent Castration Sensitive Prostate Cancer After Radical Prostatectomy PHASE2 The purpose of this study is to find out what effects, good and/or bad, tak...
Show More Location
Memorial Sloan Kettering Cancer Center
Learn More & Join Trial
Phase II Study of Docetaxel Before Degarelix in Patients With Newly Diagnosed Metastatic Prostate Cancer. PHASE2 The purpose of this study is to look at patient outcomes when docetaxel is ...
Show More Location
Medical University of South Carolina
Learn More & Join Trial
Toxicity Comparison Between Hypofractionated Radiotherapy With HDR Brachytherapy Boost Versus Standard Treatment NA The purpose of this study is to compare toxicities between 2 external beam ...
Show More Learn More & Join Trial
Neoadjuvant Study Investigating Degarelix in Patients Suffering From Prostate Cancer PHASE3 The purpose of this phase 3B trial was to see how well a new trial drug (de...
Show More Location
Alabama Research Center
Learn More & Join Trial
Assessing Efficacy of Neoadjuvant ADT in Localized High-Risk Prostate Cancer Patients Utilizing 18F-Flotufolastat PSMA PET/CT PHASE2 The purpose of this research study is to test the efficacy of ADT on prosta...
Show More Location
Miami Cancer Institute at Baptist Health, Inc.
Learn More & Join Trial
Safety and Efficacy of TAK-385 for Patients With Localized Prostate Cancer PHASE2 The purpose of this study is to evaluate the efficacy of TAK-385 for achiev...
Show More Location
Multiple Locations
Learn More & Join Trial
Extension Study Investigating the Long-Term Safety and Tolerability of Repeat Doses of FE200486 in Prostate Cancer Patients PHASE2 Participants responding well in Study FE200486 CS06 (NCT00117949) were give...
Show More Location
Advanced Urology Medical Center
Learn More & Join Trial
Symptomatic Study Investigating Degarelix in Patients Suffering From Prostate Cancer PHASE3 The purpose of this trial was to see how well a new trial drug (degarelix) ...
Show More Location
Facharztpraxis für Urologie
Learn More & Join Trial